Heterobicyclic sulfonamides
US5276025A · kind A · utility
7Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 1992 |
| Grant date | Jan 4, 1994 |
| Priority date | — |
| Expiry date | Sep 9, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of general formula: ##STR1## are topically effective carbonic anhydrase inhibitors useful in the treatment of ocular hypertension and related disorders such as glaucoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.